⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13201151 | 1.00 | — | — | |
| SCHEMBL13201148 | 1.00 | — | — | |
| SCHEMBL264756 | 1.00 | — | — | |
| SCHEMBL30531154 | 0.78 | — | — | |
| SCHEMBL17765482 | 0.77 | — | — | |
| SCHEMBL18912694 | 0.77 | — | — | |
| SCHEMBL172377 | 0.77 | — | — | |
| SCHEMBL17765481 | 0.77 | — | — | |
| SCHEMBL1665005 | 0.77 | — | — | |
| SCHEMBL13201276 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10030044-B2 | Nucleotides for the treatment of liver cancer | IDENIX PHARMACEUTICALS LLC (US) | 2018-07-24 | — | — | US | disclosed |
| US-20170029456-A1 | NUCLEOTIDES FOR THE TREATMENT OF LIVER CANCER | IDENIX PHARMACEUTICALS LLC (US) | 2017-02-02 | — | — | US | disclosed |
| US-8334364-B2 | High-molecular weight derivative of nucleic acid antimetabolite | NIPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-12-18 | — | — | US | disclosed |
| US-8334364-B2 | High-molecular weight derivative of nucleic acid antimetabolite | NIPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-12-18 | — | — | US | disclosed |
| US-8188222-B2 | High molecular weight derivative of nucleic acid antimetabolite | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-05-29 | — | — | US | disclosed |
| US-8188222-B2 | High molecular weight derivative of nucleic acid antimetabolite | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-05-29 | — | — | US | disclosed |
| US-20100029849-A1 | HIGH MOLECULAR WEIGHT DERIVATIVE OF NUCLEIC ACID ANTIMETABOLITE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20100029849-A1 | HIGH MOLECULAR WEIGHT DERIVATIVE OF NUCLEIC ACID ANTIMETABOLITE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20090281300-A1 | HIGH-MOLECULAR WEIGHT DERIVATIVE OF NUCLEIC ACID ANTIMETABOLITE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-11-12 | — | — | US | disclosed |
| US-20090281300-A1 | HIGH-MOLECULAR WEIGHT DERIVATIVE OF NUCLEIC ACID ANTIMETABOLITE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-11-12 | — | — | US | disclosed |
| EP-2080779-A1 | POLYMERIC DERIVATIVE OF NUCLEIC ACID METABOLIC ANTAGONIST | Nippon Kayaku Kabushiki Kaisha (JP) | 2009-07-22 | — | — | EP | disclosed |